Dario Recenti

Azienda USL di Bologna

Papers

2

Total Citations

46

H-Index

2

About

Dario Recenti is a researcher whose work sits at the intersection of surgical oncology and minimally invasive urology, with a particular focus on improving outcomes for patients with renal and bladder cancers. His most cited study, a 2021 propensity score-matched analysis, directly compares percutaneous ablation to minimally invasive partial nephrectomy for cT1a renal masses, providing critical evidence to guide treatment decisions for small kidney tumors. This work, which has garnered 27 citations, helps clarify the oncologic trade-offs between preserving nephrons through surgery and the lower morbidity of ablation. In a second highly cited paper (19 citations), Recenti demonstrates how the robotic approach significantly enhances the effectiveness of Enhanced Recovery After Surgery (ERAS) protocols following radical cystectomy, showing that technology and perioperative care can synergize to improve patient recovery. His research is notable for its pragmatic, comparative effectiveness design, offering surgeons and patients data-driven insights into complex treatment choices. By quantifying the real-world benefits of robotic surgery within structured recovery pathways, Recenti contributes to the ongoing refinement of urologic cancer care, balancing oncologic rigor with quality of life.

Research Focus

Key Achievements

2
H-Index
2
Papers
46
Total Citations
23
Avg Citations/Paper
🏆 Most Cited Paper
Percutaneous ablation or minimally invasive partial nephrectomy for cT1a renal masses? A propensity score‐matched analysis
27 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: Azienda USL di Bologna

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago